Home/Filings/4/0001399529-21-000010
4//SEC Filing

Ciappenelli Robert D. 4

Accession 0001399529-21-000010

CIK 0001399529other

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 9:35 PM ET

Size

18.0 KB

Accession

0001399529-21-000010

Insider Transaction Report

Form 4
Period: 2021-01-08
Ciappenelli Robert D.
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-01-08+5,7755,775 total
  • Tax Payment

    Common Stock

    2021-01-08$23.29/sh2,002$46,6273,773 total
  • Exercise/Conversion

    Restricted Stock Units

    2021-01-085,77517,325 total
    Common Stock (5,775 underlying)
  • Award

    Restricted Stock Units

    2021-01-12+13,70013,700 total
    Common Stock (13,700 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2021-01-12+61,50061,500 total
    Exercise: $24.05Exp: 2031-01-11Common Stock (61,500 underlying)
Footnotes (5)
  • [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
  • [F2]Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
  • [F3]The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of January 8, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date.
  • [F4]The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of December 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date.
  • [F5]The option vests in 48 substantially equal monthly installments, with the first installment vesting on the last day of January 2021, and the remaining shares vesting on the last day of each of the 47 months thereafter; subject in each case to the Reporting Person's continued employment or service with the Issuer through each applicable vesting date.

Issuer

Dicerna Pharmaceuticals Inc

CIK 0001399529

Entity typeother

Related Parties

1
  • filerCIK 0001778786

Filing Metadata

Form type
4
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 9:35 PM ET
Size
18.0 KB